Epitalon (Epithalon): Pineal Tetrapeptide Research Overview

What is Epitalon?

Epitalon (also spelled Epithalon) is a synthetic tetrapeptide — a short chain of four amino acids, Ala-Glu-Asp-Gly (AEDG) — studied in the laboratory for effects on telomerase and the pineal gland’s melatonin rhythm. It was designed from the composition of epithalamin, a peptide extract of the pineal gland, to give a single defined molecule. It is sold only as a research chemical for in vitro (lab) use, not for use in people or animals.

The pineal gland is a tiny structure deep in the brain that helps run the body’s daily clock, largely through the hormone melatonin. Researchers originally worked with a crude pineal extract (epithalamin); Epitalon is the simplified four-amino-acid peptide derived from it, which makes experiments more reproducible.

Most of what is published about Epitalon concerns three research areas: telomerase (an enzyme linked to how cells age), melatonin and circadian rhythm, and ageing endpoints in model organisms. Importantly, this is a small and largely older body of work — see the evidence note below before drawing any conclusions. These are research observations only, not therapeutic effects.

Mechanism, as studied

Telomerase observations (in vitro)

The most-cited finding is that adding Epitalon to cultured human cells that normally lack telomerase activity switched on expression of the telomerase catalytic subunit (hTERT), raised telomerase activity, and lengthened telomeres (the protective caps on the ends of chromosomes). This was a cell-culture observation, interpreted as reactivation of the telomerase gene. It is a single-group result and has not been broadly replicated.

Pineal and melatonin regulation

Separate studies report that pineal peptides including Epitalon can shift the daily melatonin rhythm — for example, restoring a more normal night-time melatonin pattern in aged animal models and small human samples. These are again limited, small studies.

Ageing endpoints in animals

Rodent work has looked at lifespan and tumour incidence, with mixed results — some reports of effects on maximum lifespan or specific tumour types, but no consistent increase in average lifespan. None of this supports any anti-ageing claim; it is preclinical research only.

Key research findings

The following peer-reviewed studies are summarised for scientific reference only. Note that several are from the same research group and appear in specialist journals; the literature is limited.

A note on the evidence base

Unlike compounds with large independent literatures, Epitalon’s research is limited, often older, and dominated by one research group (the St Petersburg Institute of Bioregulation and Gerontology). Key findings such as telomerase activation rest largely on single-group reports that have not been confirmed by broad independent replication. We present this material for transparent scientific reference and make no therapeutic or anti-ageing claims. Researchers should weigh these limitations when interpreting the work.

Velox Peptides supply information

Velox Peptides supplies Epitalon as a lyophilised (freeze-dried) powder, tested by HPLC with a batch certificate of analysis available on request. To reconstitute the powder for lab work, see the reconstitution calculator. Common storage conventions (keep the sealed powder cold and dry; refrigerate any reconstituted solution, protect from light, and avoid repeated freeze-thaw) are handling guidance, not validated specifications. Sold only as a research chemical for in vitro use.

Frequently asked questions